UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

4 Gy versus 24 Gy radiotherapy for follicular and marginal zone lymphoma (FoRT): long-term follow-up of a multicentre, randomised, phase 3, non-inferiority trial

The lancet oncology, 2021-03, Vol.22 (3), p.332-340

2021

Volltextzugriff (PDF)

Accelerated versus standard epirubicin followed by cyclophosphamide, methotrexate, and fluorouracil or capecitabine as adjuvant therapy for breast cancer in the randomised UK TACT2 trial (CRUK/05/19): a multicentre, phase 3, open-label, randomised, controlled trial

The lancet oncology, 2017-07, Vol.18 (7), p.929-945

2017

Volltextzugriff (PDF)

Dose-escalated simultaneous integrated boost radiotherapy in early breast cancer (IMPORT HIGH): a multicentre, phase 3, non-inferiority, open-label, randomised controlled trial

The Lancet (British edition), 2023-06, Vol.401 (10394), p.2124-2137

2023

Volltextzugriff (PDF)

Epirubicin and Cyclophosphamide, Methotrexate, and Fluorouracil as Adjuvant Therapy for Early Breast Cancer

The New England journal of medicine, 2006-11, Vol.355 (18), p.1851-1862

2006

Volltextzugriff (PDF)

Acute skin toxicity associated with a 1-week schedule of whole breast radiotherapy compared with a standard 3-week regimen delivered in the UK FAST-Forward Trial

Radiotherapy and oncology, 2016-07, Vol.120 (1), p.114-118

2016

Volltextzugriff (PDF)

Ten-year Audit of Melanoma in a Central England Population

Acta dermato-venereologica, 2011-06, Vol.91 (4), p.440-443

2011

Volltextzugriff (PDF)

When the World Throws You a Curve Ball: Lessons Learned in Breast Cancer Management

American Society of Clinical Oncology educational book, 2021-03, Vol.41 (41), p.1-e89

2021

Volltextzugriff (PDF)

Risk of premature menopause after treatment for Hodgkin's lymphoma

JNCI : Journal of the National Cancer Institute, 2014-09, Vol.106 (9), p.1

2014

Volltextzugriff (PDF)

First results of the randomised UK FAST Trial of radiotherapy hypofractionation for treatment of early breast cancer (CRUKE/04/015)

Radiotherapy and oncology, 2011-07, Vol.100 (1), p.93-100

2011

Volltextzugriff (PDF)

The impact of dose heterogeneity on late normal tissue complication risk after hypofractionated whole breast radiotherapy

Radiotherapy and oncology, 2012-08, Vol.104 (2), p.143-147

2012

Volltextzugriff (PDF)

Does acupuncture influence the vasomotor symptoms experienced by breast cancer patients taking tamoxifen?

Acupuncture in medicine : journal of the British Medical Acupuncture Society, 2000-06, Vol.18 (1), p.28-28

2000

Volltextzugriff (PDF)

Hypofractionated breast radiotherapy for 1 week versus 3 weeks (FAST-Forward): 5-year efficacy and late normal tissue effects results from a multicentre, non-inferiority, randomised, phase 3 trial

The Lancet (British edition), 2020-05, Vol.395 (10237), p.1613-1626

2020

Volltextzugriff (PDF)

Abstract P2-15-02: HER2 discordant results in local vs. central testing in the phase 3 nelipepimut-S trial and implementation of Leica Bond Oracle HER2 Immunohistochemistry (IHC) System for low and intermediate levels (1+, 2+) of HER2 protein expression as a companion diagn

Cancer research (Chicago, Ill.), 2015-05, Vol.75 (9_Supplement), p.P2-P2-15-02

2015

Volltextzugriff (PDF)

New Insights on the Pathogenesis and Treatment of Crystal Arthritis

Rheumatology (Oxford, England), 2013-04, Vol.52 (suppl 1), p.i1-i7

2013

Volltextzugriff (PDF)

Large breast size as a risk factor for late adverse effects of breast radiotherapy: Is residual dose inhomogeneity, despite 3D treatment planning and delivery, the main explanation?

Radiotherapy and oncology, 2011-08, Vol.100 (2), p.236-240

2011

Volltextzugriff (PDF)

Quality assurance analysis of participating centres' protocol compliance to a UK multicentre hypofractionated breast (FAST) trial

British journal of radiology, 2012-09, Vol.85 (1017), p.e647-e653

2012

Volltextzugriff (PDF)

The safety of intravenous chemotherapy and zidovudine when treating epidemic Kaposi's sarcoma

AIDS (London), 1989-07, Vol.3 (7), p.457-460

1989

Volltextzugriff (PDF)

Salvage mastectomy after failed breast-conserving therapy for carcinoma of the breast

Annals of the Royal College of Surgeons of England, 1991-03, Vol.73 (2), p.126

1991

Volltextzugriff (PDF)

Lymphomas

Upper Gastrointestinal Surgery, 2005, p.231-240

2005

Volltextzugriff (PDF)

Histological Abnormalities in Children with Nonalcoholic Fatty Liver Disease and Normal or Mildly Elevated Alanine Aminotransferase Levels

The Journal of pediatrics, 2014-04, Vol.164 (4), p.707-713.e3

2014

Volltextzugriff (PDF)

1 – 25 von 76

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(72)
Mit Volltextzugriff
(67)

Publikationsform

Sprache

Englisch
(76)

Erscheinungsjahr

n.n

Thema

Life Sciences & Biomedicine
(51)
Science & Technology
(51)
Humans
(44)
Female
(40)
Breast Cancer
(22)
Middle Aged
(20)
Oncology
(19)
Adult
(16)
Male
(16)
Biological And Medical Sciences
(13)
Breast Neoplasms - Radiotherapy
(13)
Aged
(12)
Breast Neoplasms - Pathology
(11)
Hematology, Oncology And Palliative Medicine
(11)
Medical Sciences
(11)
Cancer Therapies
(10)
Chemotherapy
(10)
Follow-Up Studies
(10)
Clinical Trials
(9)
General & Internal Medicine
(9)

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

4 Gy versus 24 Gy radiotherapy for follicular and marginal zone lymphoma (FoRT): long-term follow-up of a multicentre, randomised, phase 3, non-inferiority trial

Accelerated versus standard epirubicin followed by cyclophosphamide, methotrexate, and fluorouracil or capecitabine as adjuvant therapy for breast cancer in the randomised UK TACT2 trial (CRUK/05/19): a multicentre, phase 3, open-label, randomised, controlled trial

Dose-escalated simultaneous integrated boost radiotherapy in early breast cancer (IMPORT HIGH): a multicentre, phase 3, non-inferiority, open-label, randomised controlled trial

Fulvestrant plus anastrozole or placebo versus exemestane alone after progression on non-steroidal aromatase inhibitors in postmenopausal patients with hormone-receptor-positive locally advanced or metastatic breast cancer (SoFEA): a composite, multicentre, phase 3 randomised trial

Epirubicin and Cyclophosphamide, Methotrexate, and Fluorouracil as Adjuvant Therapy for Early Breast Cancer

Acute skin toxicity associated with a 1-week schedule of whole breast radiotherapy compared with a standard 3-week regimen delivered in the UK FAST-Forward Trial

2 years versus 1 year of adjuvant trastuzumab for HER2-positive breast cancer (HERA): an open-label, randomised controlled trial

Ten-year Audit of Melanoma in a Central England Population

When the World Throws You a Curve Ball: Lessons Learned in Breast Cancer Management

Risk of premature menopause after treatment for Hodgkin's lymphoma

First results of the randomised UK FAST Trial of radiotherapy hypofractionation for treatment of early breast cancer (CRUKE/04/015)

The impact of dose heterogeneity on late normal tissue complication risk after hypofractionated whole breast radiotherapy

Does acupuncture influence the vasomotor symptoms experienced by breast cancer patients taking tamoxifen?

Hypofractionated breast radiotherapy for 1 week versus 3 weeks (FAST-Forward): 5-year efficacy and late normal tissue effects results from a multicentre, non-inferiority, randomised, phase 3 trial

Abstract P2-15-02: HER2 discordant results in local vs. central testing in the phase 3 nelipepimut-S trial and implementation of Leica Bond Oracle HER2 Immunohistochemistry (IHC) System for low and intermediate levels (1+, 2+) of HER2 protein expression as a companion diagn

New Insights on the Pathogenesis and Treatment of Crystal Arthritis

Large breast size as a risk factor for late adverse effects of breast radiotherapy: Is residual dose inhomogeneity, despite 3D treatment planning and delivery, the main explanation?

Quality assurance analysis of participating centres' protocol compliance to a UK multicentre hypofractionated breast (FAST) trial

The safety of intravenous chemotherapy and zidovudine when treating epidemic Kaposi's sarcoma

Salvage mastectomy after failed breast-conserving therapy for carcinoma of the breast

Lymphomas

FAST-Forward Phase III Randomised Controlled Trial of 1-Week Hypofractionated Breast Radiotherapy: 5-Year Results for Efficacy and Late Normal Tissue Effects

European Society for Radiotherapy and Oncology Advisory Committee in Radiation Oncology Practice consensus recommendations on patient selection and dose and fractionation for external beam radiotherapy in early breast cancer

Capivasertib Plus Paclitaxel Versus Placebo Plus Paclitaxel As First-Line Therapy for Metastatic Triple-Negative Breast Cancer: The PAKT Trial

Histological Abnormalities in Children with Nonalcoholic Fatty Liver Disease and Normal or Mildly Elevated Alanine Aminotransferase Levels

Suchergebnisse filtern